Brief: Sana Biotechnology Reports Q1 2021 Financial Results
May 5 (Reuters) - Sana Biotechnology Inc SANA.O :
* SANA BIOTECHNOLOGY REPORTS FIRST QUARTER 2021 FINANCIAL
RESULTS
AND BUSINESS UPDATES
* Q1 NON-GAAP LOSS PER SHARE $0.45
* Q1 LOSS PER SHARE $1.52
Source text for Eikon: ID:nGNX3DqfMB
Further company coverage: SANA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sana Biotechnology
See all newsSana Biotechnology Inc reports results for the quarter ended June 30 - Earnings Summary
Sana Biotechnology Q2 adjusted loss narrows, beats estimates
Brief: Sana Biotechnology Q2 Adjusted EPS USD -0.13 Vs. IBES Estimate USD -0.15
Sana Biotechnology posts Q1 adjusted loss narrower than expected, extends cash runway
Brief: Sana Biotechnology Q1 Adjusted EPS USD -0.14 Vs. IBES Estimate USD -0.17